Publications

Enzyme Replacement Therapy for Mucopolysaccharidosis Vi: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (Recombinant Human Arylsulfatase B or Rhasb) and Follow-On, Open-Label Extension Study

AuthID
P-004-MH1

Author(s)

Harmatz, P

Giugliani, R

Schwariz, I

Guffon, N

Teles, EL

Miranda, MCS

Wraith, JE

Beck, M

Arash, L

Scarpa, M

Yu, ZF

Wittes, J

Berger, KI

Newman, MS

Lowe, AM

Kakkis, E

Swiedler, SJ

Group Author(s)

MPS VI Phase 3 Study Grp

Document Type

Article

Year published

2006

Published

in JOURNAL OF PEDIATRICS, ISSN: 0022-3476

Volume: 148, Issue: 4, Pages: 533-539 (7)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.jpeds.2005.12.014

Pubmed: 16647419

Scopus: 2-s2.0-33744978567

Wos: WOS:000237409100024

Source Identifiers

ISSN: 0022-3476

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Enzyme Replacement Therapy for Mucopolysaccharidosis Vi: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (Recombinant Human Arylsulfatase B or Rhasb) and Follow-On, Open-Label Extension Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Enzyme Replacement Therapy for Mucopolysaccharidosis Vi: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (Recombinant Human Arylsulfatase B or Rhasb) and Follow-On, Open-Label Extension Study

Useful Links

Get Help